PT Murni Sadar Tbk

PT Murni Sadar Tbk

IIDX:MTMH
945.00
IDR
+20.00
(+2.16%)
18.43EPS
51.16P/E
2.01TMarket Cap
PT Murni Sadar Tbk
IDX:MTMH
(Indonesia Stock Exchange)

Recent

price

945.00

P/E

ratio

51.16

div

yld

- -

ROIC.AI

2018
2019
2020
2021
2022
2023
2024
2025
TTM
IDR
164.72
214.47
274.97
475.29
412.8
445.69
516.2
656.43
712.7
Revenue per Share
-4.08
-22.7
7.44
63.02
33.11
-6.2
2.5
21.09
18.96
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
39.67
14.05
20.46
358.28
548.06
543.39
667.82
714.62
740.6
Book Value per Share
39.55
13.1
17.83
354.19
542.07
536.1
661
710.69
736.83
Tangible Book Value per Share
2,069
2,069
2,069
2,069
1,992
2,069
2,069
2,069
2,069
Basic Weighted Avg Shares
340,724
443,646
568,777
983,160
822,286
921,914
1,067,779
1,357,852
1,474,248
Sales/Revenue/Turnover
3.51
-5.61
9.33
30.16
8.34
1.32
2.06
8.41
7.85
Operating Margin (%)
12,371
19,407
21,395
29,613
47,947
57,007
63,286
77,438
85,269
Depreciation Expense
-8,442
-46,950
15,398
130,364
65,955
-12,832
5,180
43,624
39,218
Net Income, GAAP
- -
- -
81.46
30.23
18.11
- -
72.32
40.37
42.47
Effective Tax Rate (%)
-2.48
-10.58
2.71
13.26
8.02
-1.39
0.49
3.21
2.66
Profit Margin (%)
-37,923
-114,771
-85,118
-433
34,900
-101,923
-239,199
-343,491
-315,803
Working Capital
471,403
553,399
560,684
313,189
291,600
366,690
460,826
486,264
621,359
LT Debt
92,183
50,000
50,487
757,034
1,150,485
1,148,324
1,420,052
1,516,835
1,569,722
Total Equity
- -
- -
1.33
16.36
4.23
- -
0.49
2.97
2.88
Return on Invested Capital (%)
- -
- -
4.92
17.28
7.04
- -
1.08
3.48
3.26
Return on Capital (%)
- -
-84.5
43.14
33.28
7.04
-1.14
0.41
3.05
2.68
Return on Common Equity (%)

Capital Structure

IDR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
283,201
290,945
290,382
LT Borrowings
446,591
505,551
564,558
LT Finance Leases
39,673
40,498
56,800
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
2,069
2,069
2,069
Market Capitalization
2,420,177
2,027,156
2,006,471

Working Capital

IDR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
259,941
262,171
311,758
Cash, Cash Equivalents & STI
22,313
2,612
2,199
Accounts Receivable, Net
165,783
188,227
227,709
Inventories
43,305
41,053
45,428
Total Current Liabilities
603,432
626,668
627,561
Payables & Accruals
- -
- -
- -
ST Debt
283,201
290,945
290,382
Deferred Revenue
- -
- -
- -

Growth Rates

IDR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
296.34%
6.82%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
235.9%
742.14%
Sales/Revenue/Turnover
- -
22.32%
27.17%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

IDR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
263,652
262,000
281,648
260,479
1,067,779
2025
309,387
330,555
- -
355,537
1,357,852
2026
380,097
408,059
- -
- -
- -

Quarterly Earnings Per Share

IDR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
3.39
2.13
3.63
-6.64
2.5
2025
6.69
10.17
- -
-10.25
21.09
2026
5.24
13.8
- -
- -
- -

Quarterly Dividends Per Share

IDR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
PT Murni Sadar Tbk operates private hospitals in Indonesia with a focus on oncology and cardiovascular services. Founded in 2010 and headquartered in Medan, North Sumatra, the company manages a network of facilities including Murni Teguh Memorial Hospital in Medan; Murni Teguh Rosiva Mother and Child Hospital in Medan; Murni Teguh Methodist Susanna Wesley Hospital in Medan; Eria Hospital (formerly Aminah) in Pekanbaru, Riau; Murni Teguh Sudirman Hospital in Jakarta; Aminah Ciledug Hospital in Tangerang; Murni Teguh Tuban Hospital in Bali; Murni Teguh Naripan Hospital in Bandung; Murni Teguh Pematang Siantar Hospital; and Murni Teguh Horas Insani Hospital, providing a total bed capacity exceeding 1,000 units across these locations. Core services encompass outpatient clinics such as specialist, family health, general, dental, tropical disease, travel medicine, and pain clinics; laboratory services including clinical pathology, blood bank, biomolecular/PCR, microbiology, and anatomical pathology; radiotherapy with LINAC, CT-simulator, brachytherapy, and treatment planning; radiology featuring general X-ray, ultrasonography, mammography, 128-slice CT scan, 1.5 Tesla MRI, and interventional radiology; cardiovascular diagnostics and interventions via ECG, treadmill test, echocardiography, holter monitoring, cardiac catheterization lab; endoscopy procedures like esophagoscopy, gastroscopy, colonoscopy, bronchoscopy, and ERCP; medical rehabilitation including physiotherapy, speech therapy, occupational therapy; emergency and inpatient care with ICU/ICCU/PICU/NICU; operating theaters; pharmacy; medical check-ups; IVF via Murni Teguh Smart IVF; home care; palliative care; and additional specialized offerings such as oncology chemotherapy, lifestyle clinic, and ambulance services. The company conducts operations primarily in Sumatra, Java, and Bali regions, serving diverse patient segments through its subsidiaries PT Murni Sadar Kasih Abadi, PT Sahid Sahirman Memorial Hospital, PT Medikarya Aminah Utama, and PT Rumah Sakit Ibu dan Anak Rosiva. Recent developments include the acquisition of a 90% stake in PT Riau Sarana Medika, operator of Eria Hospital in Pekanbaru, for IDR 52.4 billion completed in March 2024 to expand health service reach and enhance operational efficiency; strategic international partnerships with Asan Medical Center and Yonsei University in Korea, Harley Street Heart & Vascular Centre, Icon Cancer Centre, and National University Cancer Institute in Singapore, and Indraprastha Apollo Hospitals in India; ongoing construction of Murni Teguh Pejaten Hospital in South Jakarta and Murni Teguh Gama City in Deli Serdang; and the groundbreaking ceremony for RS Murni Teguh Ciledug on September 23, 2025, marking further expansion in Tangerang.